4//SEC Filing
Ackermann Michael 4
Accession 0001209191-21-051193
CIK 0001819790other
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 5:27 PM ET
Size
5.2 KB
Accession
0001209191-21-051193
Insider Transaction Report
Form 4
Ackermann Michael
Director10% Owner
Transactions
- Sale
Common Stock
2021-08-11$25.15/sh−621$15,619→ 1,227,348 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2021.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices with the range of $25.030 to $25.250, inclusive. The Reporting Person undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001791249
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 5:27 PM ET
- Size
- 5.2 KB